Abstract
In spite of the fact that hypertension stand out as the main vascular risk factor for developing dementia, it is essential to acknowledge the presence of other risk factors, both vascular and non-vascular that contribute to increase this risk. This study stratified the dementia risk using CAIDE (Cardiovascular Risk Factors, Aging, and Incidence of Dementia) dementia risk score in a sample of 1279 hypertensive patients from the Heart-Brain Study in Argentina and to observed the association between the risk factors include in the CAIDE score and the current cognitive status. The average age of the sample was 60.2 ± 13.5 years (71% female) and the average years of education was 9.9 ± 5.1 years. To assess the current cognitive status, we used the Mini-mental test (MMSE), the clock drawing test (CDT) and Mini-Boston test. According to CAIDE score ( ≥9 points) the risk of dementia was 40.4% in the total sample and 28.1% in the middle-life hypertensive patients (between 47 to 53 years). An inverse association was observed between CAIDE score and the results of current cognitive tests (MMSE = R2 0.9128, p < 0.0001; CDT = R2 0.9215, p < 0.0001 y Mini-Boston= R2 0.829, p < 0.0001). The CAIDE score can predict the risk of dementia in hypertensive patients and its result was associated with the current cognitive status (result of cognitive tests).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413–46.
Alzheimer’s disease International, “World Alzheimer Report 2014,” http://www.alz.co.uk/research/worldreport. Accessed July 2023.
Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, et al. Defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15:455–532.
Iadecola C. Hypertension and dementia. Hypertension. 2014;64:3–5.
Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: a Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672–713.
Zlokovic BV, Gottesman RF, Bernstein KE, Seshadri S, McKee A, Snyder H, et al. Vascular contributions to cognitive impairment and dementia (VCID): a report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop. Alzheimers Dement. 2020;16:1714–33.
Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312–8.
D’Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743–53.
Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 2006;5:735–41.
Ngandu T, Lehtisalo J, Levalahti E, Laatikainen T, Lindstrom J, Peltonen M, et al. Recruitment and baseline characteristics of participants in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)-a randomized controlled lifestyle trial. Int J Environ Res Public Health. 2014;11:9345–60.
Stephen R, Liu Y, Ngandu T, Rinne JO, Kemppainen N, Parkkola R, et al. Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition. J Alzheimers Dis. 2017;59:695–705.
Kaffashian S, Dugravot A, Elbaz A, Shipley MJ, Sabia S, Kivimäki M, et al. Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores. Neurology. 2013;80:1300–6.
Exalto LG, Quesenberry CP, Barnes D, Kivipelto M, Biessels GJ, Whitmer RA. Midlife risk score for the prediction of dementia four decades later. Alzheimers Dement. 2014;10:562–70.
Vicario A, Cerezo GH, Del Sueldo M, Zilberman J, Pawluk SM, et al. Heart-Brain Research Group in Argentina with the support of the Argentine Federation of Cardiology (FAC). Neurocognitive disorder in hypertensive patients. Heart-Brain Study. Hipertens Riesgo Vasc. 2018;35:169–76.
Cerezo GH, Conti P, De Cechio AE, Del Sueldo M, Vicario A, Heart-Brain Federal Network. The clock-drawing test as a cognitive screening tool for assessment of hypertension-mediated brain damage. Hipertens Riesgo Vasc. 2021;38:13–20.
Consenso Argentino de Hipertensión arterial. Sociedad Argentina de Cardiología (SAC). Federación Argentina de Cardiología (FAC). Sociedad Argentina de Hipertensión Arterial (SAHA). [Argentine Consensus on Arterial Hypertension. Argentine Society of Cardiology (SAC). Argentine Federation of Cardiology (FAC). Argentine Society of Arterial Hypertension (SAHA)]. Rev Argent Cardiol 2018;86:1–49.
Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of Arterial Hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41:1874–2071.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
Serrano CM, Allegri RF, Drake M, Butman J, Harris P, Nagle P, et al. Versión corta en español del test de denominación de Boston: su utilidad en el diagnóstico diferencial de la enfermedad de Alzheimer. [A shortened form of the Spanish Boston naming test: a useful tool for the diagnosis of Alzheimer’s disease]. Rev Neurol. 2001;33:624–7.
Rundek T, Gardener H, Dias Saporta AS, Loewenstein DA, Duara R, Wright CB, et al. Global vascular risk score and CAIDE dementia risk score predict cognitive function in the Northern Manhattan study. J Alzheimers Dis. 2020;73:1221–31.
Nishtala A, Preis SR, Beiser A, Devine S, Hankee L, Seshadri S, et al. Midlife cardiovascular risk impacts executive function: Framingham offspring study. Alzheimer Dis Assoc Disord. 2014;28:16–22.
Vicario A, Del Sueldo M, Fernández RA, Enders J, Zilberman J, et al. Cognition and vascular risk factors: an epidemiological study. Int J Hypertens. 2012;2012:783696 https://doi.org/10.1155/2012/783696.
Schrader B, Schrader J, Elsässer A, Bünker AM, Hillmann B, et al. Influence of cardiovascular risk factors on arterial hypertension and mild cognitive impairment in 4602 participants of the ELITE study. J Hypertens. 2020;38:2475–81.
Low A, Prats-Sedano MA, McKiernan E, Carter SF, Stefaniak JD, et al. Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study. Alzheimers Res Ther. 2022;14:154.
Heart and Brain Federal Network’s Researchers in Argentina
Alejandro E. De Cerchio3, Diego Cesario4, Paola Spósito5, Patricia Conti6, Ricardo Plunket7, José R. Romano8, Facundo Risso Patrón9
Funding
The investigation had not source of funding.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cerezo, G.H., Fernández, R.A., Enders, J.E. et al. Predicting cognitive function and dementia risk in patients with hypertension. Hypertens Res (2024). https://doi.org/10.1038/s41440-024-01650-6
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41440-024-01650-6